beta amyloid synthesis inhibitor (Cura Therapeutics)

N/A

Report date: 2025/06/11 10:41:47
NME

Base Information

Drug Namebeta amyloid synthesis inhibitor (Cura Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCura Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCura Therapeutics
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A